0.60
Supernus Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.73
FY23:
0.49
FY24:
0.69
FY25:
0.64
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.09
FY22:
0.97
FY23:
0.78
FY24:
0.68
FY25:
0.81
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.69
FY22:
1.70
FY23:
1.28
FY24:
1.37
FY25:
1.45
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
0.69
FY23:
0.29
FY24:
0.29
FY25:
0.34
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.56
FY22:
0.13
FY23:
0.07
FY24:
0.04
FY25:
0.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.82
FY22:
0.89
FY23:
0.92
FY24:
1.04
FY25:
1.06
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.69
FY22:
1.70
FY23:
1.28
FY24:
1.37
FY25:
1.45
All amounts in billions USD